Clinical Ink Blog Clinical ink announces exclusive clinical trial license for the SPUR AI-enabled Digital Engagement and Retention Solution

Clinical ink, a global life science technology company, announces the promotion of John Pappadakis from EVP, Global Business Development to Chief Commercial Officer and Megan Petrylak from EVP, Clinical Operations to Chief Operating Officer.The post Clinical ink announces exclusive clinical trial license for the SPUR AI-enabled Digital Engagement and Retention Solution appeared first on Clinical ink.